Alkermes plc has undergone a transformation, shifting from a drug delivery and formulation company to an innovative pharma company. The group recently completed the spin-out of its oncology business and narrowed its focus to diseases of the central nervous system.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?